TrialBone marrow transplantation2016

Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms.

A Hanif et al.PubMed ↗Publisher ↗

No numbers read from the abstract.